pharmafield logo - pharma news

How’s your account management?

Is pharma getting account management right?
pharmafield logo - pharma news

Outcomes – the new targets

Are outcomes the new targets? Di Spencer, Pf Web Editor, explores.
pharmafield logo - pharma news

The unsung heroines of primary care

By Industry Insider
pharmafield logo - pharma news

The iPad: indispensible tool or impractical toy?

In a recent poll, you (users of Pf’s website) voted in favour of the use of the iPad by the pharmaceutical sales force.
pharmafield logo - pharma news

The life and times of a drug

Pf's Industry Insider offers a sentimental viewpoint on the rise and fall of Avandia.
pharmafield logo - pharma news

Creating the right impression, part 1

By Sarah Setterfield, Impact for Success.
pharmafield logo - pharma news

The new UK pharma Code

By Dr R K Powar, owner of R11OSY Consultants and a member of the Association for Coaching.
pharmafield logo - pharma news

The Pf Survey: What is most important to pharma employees?

  The Pf Company Perception, Motivation and Satisfaction Survey gives respondents from the medical sales sector the opportunity to have their say on their...

Latest articles

Government launches call for evidence to improve women's health and care

Government launches call for evidence to improve women’s health and care

The government is launching a 12-week call for evidence to better understand women’s experiences of the health and care system. Launching to coincide with International...
COVID-19 one year on - key changes

COVID-19 and key changes one year on

One year on from the first confirmed case of COVID-19 in the UK, Oli Hudson, Content Director at Wilmington Healthcare, takes a look at...
FDA approval for Roche’s Actemra/RoActemra in lung disease

FDA approves Roche’s Actemra/RoActemra for interstitial lung disease

Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Actemra®/RoActemra® (tocilizumab) subcutaneous injection for slowing the rate of decline in...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Nasal spray to protect against COVID-19 is ready for use in humans

Nasal spray to protect against COVID-19 is ready for use in humans

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...

Pharma marketing: UK vs US

    Marketing medicines is a totally different ball game on each side of the pond. The US is the only country, apart from New Zealand, which...
Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment

The role of women in the NHS in England

This International Women’s Day, NHS Digital has published an analysis of the role of women in the NHS in England. Women account for more than...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription